Presentation
Systemically delivered Doxil® increases survival in both an intracranial gliosarcoma model and an intracranial metastatic breast cancer model in rodents.
American Association of Neurological Surgeons 79th Annual Meeting
(2011)
Disciplines
Publication Date
April, 2011
Location
Denver, CO
Citation Information
Robert T Wicks. "Systemically delivered Doxil® increases survival in both an intracranial gliosarcoma model and an intracranial metastatic breast cancer model in rodents." American Association of Neurological Surgeons 79th Annual Meeting (2011) Available at: http://works.bepress.com/robert-wicks/38/